IMTX
Immatics NV
NASDAQ: IMTX · HEALTHCARE · BIOTECHNOLOGY
$10.99
-1.87% today
Updated 2026-04-30
Market cap
$1.50B
P/E ratio
—
P/S ratio
31.12x
EPS (TTM)
$-1.89
Dividend yield
—
52W range
$4 – $12
Volume
0.5M
Immatics NV (IMTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-196.80%
ROE
-37.10%
ROA
-18.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $3.77M | $-31.44M | -801.09% | -912.71% | -834.06% |
| 2019 | $18.45M | $-31.74M | -117.31% | -178.94% | -172.05% |
| 2020 | $31.25M | $-229.35M | -114.65% | -223.07% | -733.84% |
| 2021 | $34.76M | $-95.06M | -151.92% | -248.24% | -273.45% |
| 2022 | $172.83M | $37.51M | 38.22% | 17.33% | 21.71% |
| 2023 | $54.00M | $-96.99M | -119.76% | -188.39% | -179.63% |
| 2024 | $155.84M | $15.22M | 100.00% | -24.78% | 9.77% |
| 2025 | $48.27M | $-188.69M | 100.00% | -371.65% | -390.95% |